Form 8-K - Current report:
SEC Accession No. 0001513162-19-000191
Filing Date
2019-08-27
Accepted
2019-08-27 16:50:15
Documents
2
Period of Report
2019-08-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 26163
2 EXHIBIT 99.1 exhibit99_1.htm EX-99.1 76678
  Complete submission text file 0001513162-19-000191.txt   104102
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-37492 | Film No.: 191058048
SIC: 8071 Services-Medical Laboratories